Skip to main content
TipRanks
Go Ultimate75% OFF

OnKure Therapeutics (OKUR) Ratios

441 Followers

OnKure Therapeutics Ratios

OKUR's free cash flow for Q3 2026 was $-13.11M. For the 2026 fiscal year, OKUR's free cash flow was decreased by $-32.00K and operating cash flow was $-13.08M. See a summary of the company’s cash flow.

Financial ratios
RatiosDec 25Dec 24Dec 23Dec 22Dec 21
Liquidity Ratios
Current Ratio10.2810.734.642.4624.79
Quick Ratio10.2810.734.642.4624.79
Cash Ratio9.9710.524.102.0820.10
Solvency Ratio-9.89-4.69-0.25-0.41-5.83
Operating Cash Flow Ratio-8.75-4.85-4.74-4.86-6.12
Short-Term Operating Cash Flow Coverage0.000.000.000.000.00
Net Current Asset Value$ 54.91M$ 101.92M$ -103.81M$ -56.79M$ 146.92M
Leverage Ratios
Debt-to-Assets Ratio0.010.010.020.040.00
Debt-to-Equity Ratio0.010.01-0.01-0.010.00
Debt-to-Capital Ratio0.010.01-0.01-0.010.00
Long-Term Debt-to-Capital Ratio0.000.000.000.000.00
Financial Leverage Ratio1.111.11-0.35-0.291.05
Debt Service Coverage Ratio0.00-172.370.000.000.00
Interest Coverage Ratio0.00-181.290.000.000.00
Debt to Market Cap0.000.000.000.000.00
Interest Debt Per Share0.040.100.050.050.00
Net Debt to EBITDA1.002.120.840.373.14
Profitability Margins
Gross Profit Margin0.00%0.00%0.00%0.00%0.00%
EBIT Margin0.00%0.00%0.00%0.00%0.00%
EBITDA Margin0.00%0.00%0.00%0.00%0.00%
Operating Profit Margin0.00%0.00%0.00%0.00%0.00%
Pretax Profit Margin0.00%0.00%0.00%0.00%0.00%
Net Profit Margin0.00%0.00%0.00%0.00%0.00%
Continuous Operations Profit Margin0.00%0.00%0.00%0.00%0.00%
Net Income Per EBT100.00%100.00%100.00%100.00%100.00%
EBT Per EBIT94.55%96.85%95.61%99.15%99.88%
Return on Assets (ROA)-95.81%-45.84%-98.82%-184.46%-25.82%
Return on Equity (ROE)-105.93%-50.73%34.67%54.23%-27.02%
Return on Capital Employed (ROCE)-112.02%-52.11%-129.83%-284.65%-26.94%
Return on Invested Capital (ROIC)-110.93%-51.84%-128.88%-280.60%-26.94%
Return on Tangible Assets-95.81%-45.84%-98.82%-184.46%-25.82%
Earnings Yield-151.84%-45.91%-15.95%-9.50%-25.64%
Efficiency Ratios
Receivables Turnover0.000.000.000.000.00
Payables Turnover0.580.000.000.000.00
Inventory Turnover0.000.000.000.000.00
Fixed Asset Turnover0.000.000.000.000.00
Asset Turnover0.000.000.000.000.00
Working Capital Turnover Ratio0.000.000.000.000.00
Cash Conversion Cycle-630.170.000.000.000.00
Days of Sales Outstanding0.000.000.000.000.00
Days of Inventory Outstanding0.000.000.000.000.00
Days of Payables Outstanding630.170.000.000.000.00
Operating Cycle0.000.000.000.000.00
Cash Flow Ratios
Operating Cash Flow Per Share-3.83-3.83-2.59-2.02-20.93
Free Cash Flow Per Share-3.84-3.84-2.61-2.11-21.04
Dividend Paid and CapEx Coverage Ratio-1126.70-983.02-140.43-23.77-191.83
Capital Expenditure Coverage Ratio-1126.70-983.02-140.43-23.77-191.83
Operating Cash Flow Coverage Ratio-94.40-47.11-51.26-42.310.00
Operating Cash Flow to Sales Ratio0.000.000.000.000.00
Free Cash Flow Yield-132.34%-44.60%-15.71%-9.04%-24.61%
Valuation Ratios
Price-to-Earnings (P/E) Ratio-0.66-2.18-6.27-10.53-3.90
Price-to-Sales (P/S) Ratio0.000.000.000.000.00
Price-to-Book (P/B) Ratio0.701.10-2.17-5.711.05
Price-to-Free Cash Flow (P/FCF) Ratio-0.76-2.24-6.36-11.07-4.06
Price-to-Operating Cash Flow Ratio-0.76-2.24-6.41-11.53-4.08
Price-to-Earnings Growth (PEG) Ratio-0.06-0.04-0.310.12-0.02
Enterprise Value Multiple0.33-0.10-5.53-10.21-0.77
Enterprise Value-19.30M5.04M192.23M299.90M30.47M
EV to EBITDA0.33-0.10-5.53-10.21-0.77
EV to Sales0.000.000.000.000.00
EV to Free Cash Flow0.37-0.10-5.53-10.68-0.80
EV to Operating Cash Flow0.37-0.10-5.56-11.13-0.80
Tangible Book Value Per Share4.167.78-7.63-4.0881.14
Shareholders’ Equity Per Share4.167.78-7.63-4.0881.14
Tax and Other Ratios
Effective Tax Rate0.000.000.000.000.00
Revenue Per Share0.000.000.000.000.00
Net Income Per Share-4.40-3.95-2.65-2.21-21.92
Tax Burden1.001.001.001.001.00
Interest Burden1.001.011.000.991.00
Research & Development to Revenue0.000.000.000.000.00
SG&A to Revenue0.000.000.000.000.00
Stock-Based Compensation to Revenue0.000.000.000.000.00
Income Quality0.870.970.980.910.96

Currency in USD